[go: up one dir, main page]

SE8703225L - MONOCLONAL ANTIBODIES AND PEPTIDES USEFUL IN TREATMENT AND DIAGNOSTIZATION OF HIV INFECTIONS - Google Patents

MONOCLONAL ANTIBODIES AND PEPTIDES USEFUL IN TREATMENT AND DIAGNOSTIZATION OF HIV INFECTIONS

Info

Publication number
SE8703225L
SE8703225L SE8703225A SE8703225A SE8703225L SE 8703225 L SE8703225 L SE 8703225L SE 8703225 A SE8703225 A SE 8703225A SE 8703225 A SE8703225 A SE 8703225A SE 8703225 L SE8703225 L SE 8703225L
Authority
SE
Sweden
Prior art keywords
monoclonal antibodies
peptides
diagnostization
treatment
hiv infections
Prior art date
Application number
SE8703225A
Other languages
Swedish (sv)
Other versions
SE8703225D0 (en
SE506025C2 (en
Inventor
M K Shriver
E K Thomas
W L Cosand
L H Gosting
E S Dickinson
J N M I Mcclure
G J Todaro
R C Nowinski
Original Assignee
Genetic Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetic Systems Corp filed Critical Genetic Systems Corp
Publication of SE8703225D0 publication Critical patent/SE8703225D0/en
Publication of SE8703225L publication Critical patent/SE8703225L/en
Publication of SE506025C2 publication Critical patent/SE506025C2/en

Links

Classifications

    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
    • F04B—POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS
    • F04B25/00—Multi-stage pumps
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1054—Lentiviridae, e.g. HIV, FIV, SIV gag-pol, e.g. p17, p24
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • AIDS & HIV (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Mechanical Engineering (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Disclosed are monoclonal antibodies reactive with one or more neutralizing regions of HIV proteins, peptides or homologs of such neutralizing regions, and nucleic acid segments coding for said peptides. Neutralizing regions include portions of the env and gag genes from various HIV isolates. The monocional antibodies may be used to treat HIV infection or in diagnosis and the peptides may be used to elicit antibodies and to block HIV infection.
SE8703225A 1986-08-20 1987-08-19 Monoclonal antibodies and peptides and their preparations for the treatment and diagnosis of HIV infection as well as cell lines for antibody production SE506025C2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89827386A 1986-08-20 1986-08-20
US4502687A 1987-05-01 1987-05-01
US6799687A 1987-06-29 1987-06-29

Publications (3)

Publication Number Publication Date
SE8703225D0 SE8703225D0 (en) 1987-08-19
SE8703225L true SE8703225L (en) 1988-02-21
SE506025C2 SE506025C2 (en) 1997-11-03

Family

ID=27366600

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8703225A SE506025C2 (en) 1986-08-20 1987-08-19 Monoclonal antibodies and peptides and their preparations for the treatment and diagnosis of HIV infection as well as cell lines for antibody production

Country Status (28)

Country Link
JP (1) JPS6485928A (en)
KR (1) KR920008744B1 (en)
AT (1) AT398080B (en)
AU (1) AU616156B2 (en)
BE (1) BE1000811A4 (en)
CH (1) CH675728A5 (en)
CS (1) CS275838B6 (en)
DE (1) DE3727703A1 (en)
DK (1) DK433087A (en)
ES (1) ES2010727A6 (en)
FI (1) FI873553A (en)
FR (1) FR2603107B1 (en)
GB (1) GB2196634B (en)
GR (1) GR871298B (en)
HU (1) HU214439B (en)
IE (1) IE60671B1 (en)
IL (1) IL83580A (en)
IT (1) IT1222518B (en)
LU (1) LU86972A1 (en)
NL (1) NL8701950A (en)
NO (2) NO300462B1 (en)
NZ (1) NZ221440A (en)
OA (1) OA08652A (en)
PL (1) PL155084B1 (en)
PT (1) PT85567B (en)
SE (1) SE506025C2 (en)
YU (1) YU152587A (en)
ZW (1) ZW15487A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP96A (en) * 1986-06-03 1990-08-12 The Usa Dept Of Commerce Small peptides which inhibit binding to T-4 receptors and act as immunogens.
AU625720B2 (en) * 1987-05-01 1992-07-16 Genetic Systems Corporation Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use
US5981278A (en) * 1987-05-29 1999-11-09 Tanox, Inc. Chimeric monoclonal antibodies which neutralize HIV-1 infection and their applications in therapy and prevention for AIDS
DE3853779T2 (en) * 1987-05-29 1995-09-07 Baylor College Medicine HIV-1 NEUTRALIZING MONOCLONAL ANTIBODIES.
US6657050B1 (en) 1987-05-29 2003-12-02 Tanox, Inc. Chimeric viral-neutralizing immunoglobulins
US5834599A (en) * 1987-05-29 1998-11-10 Tanox Biosystems, Inc. Immunoconjugates which neutralize HIV-1 infection
WO1989007112A1 (en) * 1988-01-26 1989-08-10 The United States Of America, As Represented By Th A synthetic antigen evoking anti-hiv response
CA1341285C (en) * 1988-02-12 2001-08-14 Chang Yi Wang Synthetic peptides for the detection of antibodies to hiv gp120 envelope protein for diagnosis of aids and pre-aids conditions and as vaccines
IL90048A0 (en) * 1988-04-25 1989-12-15 Merck & Co Inc Recombinant gag precursor of hiv,its preparation and its use as aids vaccine
US5562905A (en) * 1988-04-26 1996-10-08 E. I. Du Pont De Nemours And Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
EP0339504A3 (en) * 1988-04-26 1990-09-12 The Du Pont Merck Pharmaceutical Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
FR2632310B1 (en) * 1988-06-06 1992-04-10 Pasteur Institut PEPTIDES HAVING PROTECTIVE PROPERTIES OF A PATHOGENIC VIRUS OF THE HIV TYPE IN SENSITIVE CELLS
WO1990003984A1 (en) * 1988-10-03 1990-04-19 Repligen Corporation Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
EP0421626A1 (en) * 1989-09-19 1991-04-10 Merck & Co. Inc. Vaccine for aids and hepatitis B
SE9000333D0 (en) * 1990-01-31 1990-01-31 Britta Wahren MONOCLONAL ANTIBODY
SE468168B (en) * 1990-02-20 1992-11-16 Replico Medical Ab HIV-1, P24 PEPTIDES, DIAGNOSTIC ANTIGENS AND PROCEDURES FOR DIFFERENTIAL DIAGNOSTICS OF PRELIMINARY HIV-1 POSITIVE SERUM TESTS
JPH03271233A (en) * 1990-03-19 1991-12-03 Inst Pasteur Induction of protection against viral infection by synergy between viral envelope glycoproteins and peptides corresponding to neutralizing epitopes of the glycoproteins
CA2047078A1 (en) * 1990-07-19 1992-01-20 Steven S. Bondy Cyclic hiv principal neutralizing determinant peptides
CA2047042A1 (en) * 1990-07-19 1992-01-20 John Hannah Cyclic hiv principal neutralizing determinant peptides
JPH05310785A (en) * 1991-09-30 1993-11-22 Nitto Denko Corp Hiv-related cyclic peptide and adsorption material obtained by immobilizing the same
ATE267838T1 (en) * 1992-03-27 2004-06-15 Advanced Immuni T Inc T-PEPTIDE AND RELATED PEPTIDES IN THE TREATMENT OF INFLAMMATION INCLUDING MULTIPLE SCLEROSIS
EP1976548B1 (en) 2005-12-09 2014-07-02 Vectus Biosystems Limited VIP fragments and compositions thereof
EP2323233B1 (en) 2008-09-02 2017-10-11 NGK Spark Plug Co., Ltd. Spark plug
KR102727239B1 (en) * 2022-09-07 2024-11-07 한국세라믹기술원 Magnesium oxide powder and method for manufacturing the same

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9328391B1 (en) * 1984-08-22 2016-05-03 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Cloning and expression of HIV-1 DNA
ES8705522A1 (en) * 1984-10-18 1987-05-01 Pasteur Institut A PROCEDURE FOR THE PREPARATION OF PURIFIED DERIVATIVES OF A GLYCOPROTEIN.
GB8501473D0 (en) * 1985-01-21 1985-02-20 Pasteur Institut Cloned dna sequences
CA1341423C (en) * 1984-10-31 2003-03-04 Paul A. Luciw Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
IE64785B1 (en) * 1985-04-08 1995-09-06 Genetic Systems Corp Expression of immunologically reactive viral proteins
CA1341384C (en) * 1985-04-08 2002-08-20 Susan Mitsue Watanabe Expression and diagnostic use of gag encoded peptides which are immunologically reactive with antibodies to lav
DK171119B1 (en) * 1985-04-19 1996-06-17 Hoffmann La Roche AIDS virus envelope protein, expression vector carrying the envelope protein, transformants transformed with the expression vector, method of producing the virus envelope protein, method of detecting AIDS antibodies, method of determining AIDS virus, vaccine against AIDS, antibodies against the virus envelope protein and use of it to prepare a vaccine and for testing
DE3650175T3 (en) * 1985-04-29 2007-09-06 Bio-Rad Laboratories, Inc., Hercules SYNTHETIC ANTIGENIC TO IDENTIFY AIDS.
GB8525615D0 (en) * 1985-10-17 1985-11-20 Hoffmann La Roche Polypeptides
JPS63501716A (en) * 1985-10-24 1988-07-14 サウスウエスト・ファウンデ−ション・フォア・バイオメディカル・リサ−チ Synthetic peptides and their use for diagnosis of AIDS and ARC and vaccine injections
WO1987002988A1 (en) * 1985-11-07 1987-05-21 President And Fellows Of Harvard College T-cell lymphotrophic virus protein and assay
US4734362A (en) * 1986-02-03 1988-03-29 Cambridge Bioscience Corporation Process for purifying recombinant proteins, and products thereof
US4772547A (en) * 1986-02-03 1988-09-20 Hoffmann-La Roche Inc. HTLV-III envelope peptides
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein
IE63109B1 (en) * 1986-06-23 1995-03-22 Genetic Systems Corp Human monoclonal antibody to lymphadenopathy-associated virus
EP0255190A3 (en) * 1986-08-01 1990-08-29 Repligen Corporation Recombinant polypeptides and their uses, inclusing assay for aids virus
EP0273716B1 (en) * 1986-12-30 1993-08-11 THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce Synthetic peptides which induce cellular immunity to the aids virus and aids viral proteins

Also Published As

Publication number Publication date
NO302176B1 (en) 1998-02-02
KR920008744B1 (en) 1992-10-09
CH675728A5 (en) 1990-10-31
BE1000811A4 (en) 1989-04-11
FR2603107A1 (en) 1988-02-26
YU152587A (en) 1992-09-07
ES2010727A6 (en) 1989-12-01
NO934897D0 (en) 1993-12-29
NL8701950A (en) 1988-03-16
FI873553A (en) 1988-02-21
HUT44619A (en) 1988-03-28
IT1222518B (en) 1990-09-05
AU616156B2 (en) 1991-10-24
FI873553A0 (en) 1987-08-17
IT8721678A0 (en) 1987-08-19
AU7720187A (en) 1988-05-19
ZW15487A1 (en) 1988-09-14
IL83580A0 (en) 1988-01-31
JPS6485928A (en) 1989-03-30
IE60671B1 (en) 1994-08-10
NO873495L (en) 1988-02-22
NO934897L (en) 1993-12-29
IL83580A (en) 1992-11-15
GB2196634B (en) 1991-05-15
SE8703225D0 (en) 1987-08-19
CS275838B6 (en) 1992-03-18
NZ221440A (en) 1991-11-26
LU86972A1 (en) 1988-03-02
PT85567A (en) 1987-09-01
GR871298B (en) 1988-01-12
DK433087A (en) 1988-02-21
PL155084B1 (en) 1991-10-31
DE3727703A1 (en) 1988-05-05
PT85567B (en) 1991-02-08
OA08652A (en) 1988-11-30
CS8706136A2 (en) 1990-08-14
FR2603107B1 (en) 1992-04-24
NO300462B1 (en) 1997-06-02
KR890002547A (en) 1989-04-10
NO873495D0 (en) 1987-08-19
SE506025C2 (en) 1997-11-03
DK433087D0 (en) 1987-08-19
GB8719587D0 (en) 1987-09-23
HU214439B (en) 1998-03-30
IE872219L (en) 1988-02-20
GB2196634A (en) 1988-05-05
AT398080B (en) 1994-09-26
PL267401A1 (en) 1988-07-21
ATA208987A (en) 1994-01-15

Similar Documents

Publication Publication Date Title
SE8703225L (en) MONOCLONAL ANTIBODIES AND PEPTIDES USEFUL IN TREATMENT AND DIAGNOSTIZATION OF HIV INFECTIONS
ATE294864T1 (en) OUTER MEMBRANE PROTEIN OF HAEMOPHILUS
ATE135747T1 (en) DNA ENCODING THE T-CELL SURFACE PROTEIN T4 AND USE OF T4 FRAGMENTS IN THE TREATMENT OF AIDS
DK442688A (en) METHOD AND PREPARATION FOR TREATMENT OF NON-IGE-MEDIATED DISORDERS
ATE96033T1 (en) MEANS FOR TREATMENT OF ARTHROSIS.
DK614987A (en) SYNTHETIC HTLV-III PEPTIDES, PREPARATIONS AND APPLICATIONS THEREOF
ATE110782T1 (en) RECOMBINANT HUMAN ENDOTHELIAL CELL GROWTH FACTOR.
DK0835133T3 (en) Recombinant smallpox virus rabies and combination preparations and their uses
ATE127345T1 (en) STRESS PROTEINS AND USES THEREOF.
BR9711457A (en) Compounds and process for the treatment and diagnosis of mycobacterial infections.
DK43890D0 (en) NUCLEIC ACID, VECTORS AND CELLS CONTAINING THE PRODUCED PRODUCTS AND THEIR USE THEREOF
ATE165345T1 (en) SULFONIC ACID DERIVATIVES FOR THE TREATMENT OF VIRUS DISEASES
ATE179614T1 (en) HERPES SIMPLEX VIRUS VP16 VACCINES
ATE355375T1 (en) BACTERIOFERRITIN FROM HELICOBACTER PYLORI
MC2308A1 (en) PEPTIDES FOR VACCINATION AND INDUCTION OF NEUTRALIZING ANTIBODIES AGAINST HUMAN IMMUNODEFICIENCY VIRUS
BR9814432A (en) Compositions derived from mycobacterium vaccae and process for their use
DE3781652D1 (en) PREPARATION SUITABLE FOR TREATMENT OF COLONAL DISEASES.
DE3854550D1 (en) HIV peptides and methods for the detection of HIV.
BG99074A (en) Recombinant human hiv neutralizing monoclonal antibodies for prophylaxy and treatment of hiv infection
ATE125870T1 (en) HIV-SPECIFIC MONOCLONAL ANTIBODIES AND HYBRIDOMAS FOR THEIR PRODUCTION.
PT88913A (en) PROCESS FOR THE PREPARATION OF ANTICOAGULANT PP4-X PROTEIN
EA199700353A1 (en) Compositions and methods for detecting and treating acquired immunodeficiency syndrome
BR9711809A (en) Antigenic or immunogenic polypeptide, processes for treating or preventing a disease or disorder in an individual caused by infection with htlv-i, and with htlv-ii, to elicit in an individual the production of antibodies that specifically bind to htlv- envelope proteins ii and htlv-i, and, to generate an immune response in an individual
ATE62019T1 (en) METHODS FOR THE PRODUCTION OF HCMV GLYCOPROTEINS, ANTIBODY AND HCMV VACCINE AND RECOMBINANT VECTORS FOR USE THERETO.
SU1739559A1 (en) TREATMENT OF APHTAE EPIZOOTICAE VIRUS TYPE O, USED TO MAKE DIAGNOSTIC SERIES AND ANTIGEN DRUGS

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8703225-6

Format of ref document f/p: F